Dogwood Therapeutics, Inc.
DWTX
$1.84
$0.010.55%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 54.36% | 51.08% | -590.34% | -262.68% | -746.05% |
| Total Depreciation and Amortization | -1.18% | 36.07% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -100.00% | -- | -- | -- |
| Total Other Non-Cash Items | -92.28% | -97.77% | 12,723.75% | -59.70% | 4,515.83% |
| Change in Net Operating Assets | 53.58% | 102.05% | -71.66% | -432.21% | -213.02% |
| Cash from Operations | 2.04% | 40.68% | -259.61% | -396.01% | -399.53% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 160.67% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 53.16% | -99.79% | 100.00% | -108.27% | -- |
| Foreign Exchange rate Adjustments | -183.33% | 101.87% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 149.08% | -128.12% | -234.16% | -745.58% | 387.08% |